Bioavailability and transport of peptides and peptide drugs into the brain.
about
Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation.An in vivo study of novel bioactive peptides that inhibit the growth of Escherichia coli.CNS delivery via adsorptive transcytosis.Acrylamide exposure impairs blood-cerebrospinal fluid barrier functionImmunity and behavior: antibodies alter emotionClaulansine F promotes neuritogenesis in PC12 cells via the ERK signaling pathwayChlorogenic Acid Improves Neuroprotective Effect of PEP-1-Ribosomal Protein S3 Against Ischemic Insult.Investigating endogenous peptides and peptidases using peptidomicsThe CNS as a target for peptides and peptide-based drugs.Targeted pharmaceutical nanocarriers for cancer therapy and imagingAmyloid-β-neuropeptide interactions assessed by ion mobility-mass spectrometry.Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.Polymeric nanoparticles for the drug delivery to the central nervous system.Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptidesAnticonvulsant neuropeptides as drug leads for neurological diseases.Shuttle-mediated drug delivery to the brain.Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.Current progress on microRNAs-based therapeutics in neurodegenerative diseases.PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era.SMAR1-derived P44 peptide retains its tumor suppressor function through modulation of p53.Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin.Chimeric p53 as an alternative therapy for hypoxic tumors.Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke.Militarinone A induces differentiation in PC12 cells via MAP and Akt kinase signal transduction pathways.DhHP‑6 attenuates cerebral ischemia‑reperfusion injury in rats through the inhibition of apoptosis.Review of the potential health impact of β-casomorphins and related peptidesPhase-Separated Liposomes Enhance the Efficiency of Macromolecular Delivery to the Cellular Cytoplasm.Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.A New Noncanonical Anionic Peptide That Translocates a Cellular Blood-Brain Barrier Model.Bike peptides: a ride through the membrane.New diketopiperazines as vectors for peptide protection and brain delivery: Synthesis and biological evaluation.Tyr1-ψ[( Z)CF═CH]-Gly2 Fluorinated Peptidomimetic Improves Distribution and Metabolism Properties of Leu-Enkephalin.Photo-acceleration of protein release from endosome in the protein transduction system
P2860
Q30805913-78F4322E-F5F3-4309-8DFA-04F86D6C3834Q30826990-76A1A748-1E9E-432D-BA2D-1DA1088526C6Q34013526-0E84F4AC-CDE7-418F-BB29-D86A558FF1ABQ34128070-DD857DE8-2548-4883-A35F-5B96C8291964Q34270963-D8E40911-E7EA-43FE-AAB8-E06DD188FE62Q35008538-6FAC8B38-81F2-488E-B03A-A92E2014698DQ35707896-B3FA12B7-4C2B-42D3-A60A-5854E3DA2597Q36163374-6D9E1B04-0AA0-48E0-9C5D-C0A3E9D0384AQ36640307-216D5CF2-6B68-480E-9B3E-12BFC88B6552Q36871933-E8A0CCD6-10D2-4383-83CC-D1A1CC14B130Q36879051-50BBD906-1488-4E58-B224-2B029D64383AQ36936597-5B1922A6-2F56-441E-B124-50785D397B2DQ37076360-04793E4A-BF8A-4FFB-8EA9-11C981ED8625Q37232872-01338E17-F363-42A7-8EDB-51D4D4E7A31DQ37845684-AC6FC94C-425B-4080-A681-BB8BDF939F2BQ37896550-7BD4A609-0B77-4AB7-8CA3-F8346BC6D8BCQ38211727-980BE5A9-A816-4251-9732-D53EC24C94ECQ38791303-5E836CD4-BCF8-407D-BB33-1D6EE4404B55Q38956599-89CB1964-500D-47AC-A2F2-F16D92CACFADQ39091774-E671C7F6-985C-40C4-A405-B47D28C63B1EQ40182201-0F0899FD-8089-49D0-9D4D-3B12E42001B2Q40760933-D2A7E375-0E0C-41FD-9884-C735F33676EDQ42643279-301385C1-EEF1-4ACF-84E7-BF53035446BAQ43148430-DE8CAB65-C34F-490D-ACFB-A75A3C773760Q43847264-EA70646D-DA9E-4BB5-9BE7-5AD9D06A9736Q45158274-17C2CD5B-7A41-44A4-BA5F-BE37C09A91F3Q46301310-525D26AB-9351-406F-BB77-73A9624BA69BQ47146266-E381C211-0BB4-4519-936B-FECB2DFF01C4Q47379610-41EDD3B7-1FFE-404F-AB89-02D75092A22CQ47433079-4C5CF92B-C4AC-4643-8C75-2A75DF8E2530Q48007483-53A2ECF9-01D1-4415-B005-09BB23EA5D39Q48112273-E1C408B0-E44C-4A9F-AEBC-BB7A30CB6D4EQ48362481-3E43DC84-744F-4D47-8B50-1571EC8AB6DDQ52592115-3D28B0F0-708B-45A8-8DB4-581C7F2F7D4DQ57360742-30423209-DF17-42E6-A10F-DC943623EE25
P2860
Bioavailability and transport of peptides and peptide drugs into the brain.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Bioavailability and transport of peptides and peptide drugs into the brain.
@en
type
label
Bioavailability and transport of peptides and peptide drugs into the brain.
@en
prefLabel
Bioavailability and transport of peptides and peptide drugs into the brain.
@en
P1433
P1476
Bioavailability and transport of peptides and peptide drugs into the brain.
@en
P2093
P304
P356
10.1016/S0196-9781(97)00242-8
P577
1997-01-01T00:00:00Z